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Summary
Aims and Objectives: To identify bacterial agents of chronic discharging ear and 
determine their antibiotic sensitivities pattern in Ido – Ekiti, Nigeria.
Patients and Methods: Swab specimens of each chronically (>8 weeks) discharging 
ears of patients with chronic suppurative otitis media (CSOM) presenting to 
the Ear, Nose and Throat (ENT) clinic of the Federal Medical Centre, Ido Ekiti 
were bacteriologically cultured aerobically and the antibiotic sensitivity 
pattern of the recovered organisms determined by the modified Kirby-Bauer 
disc-diffusion method over a three year period starting from January 2005. 
Results: Seventy eight patients with CSOM whose age ranged between 3 months 
and 85 years were seen during the study period with 73.1% of them having 
unilateral disease and majority were children <15 years (71.8%). Out of 99 ear 
swabs that were examined, 87.9% were culture positive with 90.8% yielding a 
single isolate. Coliforms (34.7%) were the most frequent isolated group of 
organisms. Other isolates included Staphylococcus aureus (26.3%), Proteus 
spp (24.2%), Pseudomonas spp (9.5%) and Klebsiella spp (5.3%). Sparfloxacin 
and ciprofloxacin showed highest activity on all the isolates unlike cefuroxime 
and ceftiaxone to which all isolates were resistant.
Conclusion:  Chronic discharging ear is caused by bacteria agents most sensitive 
Introduction
Chronic suppurative otitis media (CSOM) is a chronic 
inflammation of the middle ear cleft often associated with 
perforated tympanic membrane and muco-purulent ear discharge 
1, 2, 3persisting or recurring for more than eight (8) weeks . It is a 
commonly encountered infection of the middle ear and an 
important cause of preventable hearing loss particularly in the 
4, 5developing world . CSOM is a childhood disease because 
children tend to have a higher predisposition to ear infection 
though adults are also affected and it is one of the commonest 
6-9ailments seen by Otorhinolaryngologist in Nigeria .  It occurs as 
a complication of acute otitis media, a common condition with an 
alarming propensity to become chronic in developing settings 
10due to various factors, including inadequate treatment . 
Occasionally, complications such as meningitis, brain abscess, 
facial nerve palsy, subperiosteal and mastoid abscess and even 
3, 5, 11death follows when not properly treated . Its association with 
hearing impairment, death and severe disability coupled with the 
high costs incurred in its management makes CSOM a significant 
12health  problem in developing countries . In Nigeria, a study 
done at the University of Nigeria Teaching Hospital, Enugu 
revealed that chronic middle ear infection accounted for 71% of 
13the cases of conductive deafness . As acute otitis media develops 
into a chronic infection, the underlying microbiology also 
changes markedly. Studies in various centers in Nigeria and world 
over have identified Pseudomonas aeruginosa, Staphylococcus 
aureus, Proteus spp, Klebsiella spp, among others as causative 
3, 7- 9, 11, 14-19agents of CSOM . No such studies have been carried out 
at our centre despite the global problem of antibiotic resistance. 
Besides, empirical antibiotic treatment is the rule in our setting for 
which periodic review is a necessary guide through determination 
of prevalent strains and their sensitivity pattern. This study 
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therefore was designed to determine the current bacterial agents 
of CSOM and their antibiotic sensitivity patterns in Ido - Ekiti, 
Nigeria 
Patients and Methods
This is a prospective study carried out at the ENT Clinic of 
the Federal Medical Centre (FMC), Ido Ekiti over a 3 year period 
starting from January 2005. Federal Medical Centre, Ido Ekiti is 
the only tertiary health centre located in Ekiti state, southwest, 
Nigeria. The hospital attends to the people in the Ido Ekiti 
metropolis, surrounding communities and receives referral from 
health facilities in Ekiti and neighbouring state.
All consecutive patients with discharging ears of two or 
more months presenting to the ENT Clinic of the FMC, Ido-Ekiti 
were recruited during the study period having obtained their 
consent. Patients who were on antibiotic treatment within the last 
1 week, and patient who refused to participate in the study were 
excluded. Ethical clearance was obtained from the research and 
ethical committee of the hospital. The age, sex, occupation, 
clinical presentation and previous treatment types were noted at 
recruitment.  General and otoscopic examinations were carried 
out on all patients. Ear swab specimens of each discharging ear 
was taken with a sterile cotton swab and sent for bacteriological 
examination at the Microbiology laboratory of the hospital inside 
Stuarts transport medium.  
Swabs specimens were inoculated unto blood and 
MacConkey agar plates which were incubated aerobically and 
chocolate agar which was incubated inside candle extinction jar, 
Oall at 37 C for 24 to 48 hours. Anaerobic culture was not done 
because the facility was not available at the time of the study. 
Growth on culture plates were identified by colony morphology, 
20Gram staining and standard biochemical tests . 
Antibiotics sensitivity test was performed using the 
21modified Kirby-Bauer disc-diffusion method . Pure colonies of 
the isolated organisms were suspended in sterile normal saline 
inside Bijou bottles and the turbidity of the suspension adjusted to 
0.5 McFarland's standard. A sterile cotton swab was dipped into 
the suspension and squeezed against the side of the bottle. The 
swab was then used to inoculate Mueller Hinton agar before the 
application of single antibiotic discs and subsequent incubation at 
o37 C aerobically for 24hours. Zone diameters of inhibition around 
each disc were measured using a calibrated ruler and interpreted 
according to National Committee for Clinical Laboratory 
22Standard (NCCLS)  Escherichia coli NCTC 10418, 
Staphylococcus aureus NCTC 6571 and Pseudomonas ATCC 
27853 were used as control strains as appropriate. 
The antibiotic discs used were cefuroxime (30µg), 
sparfloxacin (5ug), ceftazidime (30µg), ceftiaxone (30µg), 
gentamicin (10µg), chloramphenicol (10µg), erythromycin 
(5µg), and ciprofloxacin (5µg). 
Data obtained were entered into SPSS Version 15.0 for 
analysis and results presented in tables.
Results
Seventy-eight patients with CSOM were recruited into the 
study comprising of 46 (59.0%) males and 32 (41.0%) females 
given a M: F ratio of 1.4:1. The age of patients range between 3 
months and 85 years with 56 (71.8%) patients in the paediatric age 
group (≤15 years). The peak prevalence was in patient's ≥10 years 
old accounting for 62.8% of the patient studied (Table I). 
Unilateral CSOM were recorded in 57 (73.1%) of the patients 
while 21(26.9%) had bilateral disease. 
Of the 99 ear swabs examined, 87 (87.9%) were culture 
positive and 12 (12.1%) negative. Among the culture positive 
ones, 79 (90.8%) were single isolates (Table II). 
In all, there were 95 isolates which after typing were divided 
into five groups of bacteria comprising of Coliforms (34.7%), 
Staphylococcus aureus (26.3%), Proteus spp (24.2%), 
Pseudomonas spp (9.5%) and Klebsiella (5.3%) (Table III). Table 
IV showed that right ears of the male patients were relatively more 
affected than the female patients, Staphylococcus aureus were 
more involved where there is a   mixed growth. 
 The antibiotic sensitivity patterns of the   isolates are shown 
in Table V.   Most of the isolates were sensitive to the quinolones 
(ciprofloxacin and Sparfloxacin), but resistant to erythromycin, 
cefuroxime and ceftiaxone. There was however some degree of 
sensitivity to ceftazidime by Staphylococcus aureus (62.5%), 
Proteus spp (60.0%) and Pseudomonas (75.5%).
Table I: Age and sex distribution of patients with CSOM in Ido - Ekiti, Nigeria
Age range Male Female Total
 (years) Frequency (n)      (%) Frequency (n)     (%) Frequency (n)    (%)
d”10 31                 (39.7) 18                 (23.1) 49             ( 62.8)
11-20 4                   (  5.1) 5                   (  6.4) 9               (11.5)
21-30 4                    (  5.1) 2                   (  2.6) 6               (  7.7)
31-40 1                    (  1.3) 2                   (  2.6) 3               (  3.8)
41-50 2                    (  2.6) 3                   (  3.8) 5               (  6.4)
>50 4                   (  5.1) 2                   (  2.6) 6              (  7.7)
Total 46                  (59.0) 32                 (41.0) 78             (100.0)
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Table ii: Ear related frequency distribution of bacteria isolates of chronic ear discharge culture
ORGANISM RIGHT EAR LEFT EAR      TOTAL
(N)          (%)
Pure growth
Coliforms 23 6 29         (36.7)
Staphylococcus aureus 13 5 18          (22.8)
Proteus spp 10 10 20           (25.3)
Pseudomonas spp 3 5 8             (10.1)
Klebsiella spp 2 2 4             ( 5.1)
        TOTAL 51 28 79           (100.0)
Mixed growth
Staphylococcus aureus + Coliforms 3 1 4             (50.0)
Staphylococcus aureus + Proteus spp 2 1 3             (37.5)
Pseudomonas spp + Klebsiella spp - 1 1             (12.5)
        TOTAL 5 3 8             (100.0)
No Growth 10 2 12            (100.0)
GRAND TOTAL 66 33 99           (100.0)
Table iii: Frequency distribution of bacterial isolates among culture 
positive chronically discharging ears 
Organism Frequency N  (%)
Coliform spp 33          (34.7)
Staphylococcus spp 25          (26.3)
Proteus spp 23          (24.2)
Pseudomonas 9            (9.5)
Klebsiella 5            (5.3)
Total 95          (100)
Table iv: Distribution of bacteria isolates in pure and mixed culture by ear and sex of patients with csom
organism isolated            right ear       left ear total(n)    (%)
male female male female
Coliforms 14 8 4 3 29      ( 33.3)   
Staph. Aureus 8 5 3 2 18      ( 20.7)
Proteus spp 6 4 6 4 20       (22.9)
Pseudomonas spp 0 3 2 3 8          ( 9.2)
Klebsiella spp 1 1 1 1 4         ( 4.6)
Staph  aureus + coliforms 3 0 1 0 4         ( 4.6)
Staph aureus +proteus spp 2 0 1 0 3          (3.4)
Pseudomonas spp  + klebsiella spp - - 0 1 1        (1.1)
Total 34 21 18 14 87   (100.0)
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Table v: antimicrobial sensitivity patterns of isolates from patients with chronic suppurative otitis media
 ANTIBIOTIC Sparfloxacin  Erythromycin  Chloramphenicol Gentamicin        Ceftazidime cefuroxime Ciprofloxacin Ceftiaxone 
(5ug)(5ug) (10ug) (10ug) (30ug) (30ug) (5ug) (30ug)
ORGANISM SENSITIVITY N          (%) N          (%) N          (%) N          (%) N          (%) N          (%) N          (%) N          (%) 
Coliforms Sensitive 18 (90.0) 0 (0.0) 0 (0.0) 14 (56.0) 1 (10.0) 0 (0.0) 17 (100) 1 (5.9)
Resistant 2 (10.0) 29 (100) 18 (100) 11 (44.0) 9 (90.0) 10 (100) 0 (0.0) 16
(94.1)
   Total tested 20    (100) 29      (100) 18     (100) 25    (100) 10    (100) 10   (100) 17   (100) 17  (100)
Staphylococcus Sensitive 10    (71.4) 10      (55.6) 7      (58.3) 10    (58.8) 5     (62.5) 1    (20.0) 4     (66.7) 1    (11.1)
Aureus Resistant 4      (28.6) 8        (44.4) 5       (41.7) 7      (41.7) 3     (37.5) 4     (80.0) 2      (33.3) 8     (88.9)
Total tested 14     (100) 18      (100) 12     (100) 12    (100) 8     (100) 5   (100) 6     (100) 9    (100)
Proteus spp Sensitive 9      (81.8) 1        (5.6) 9       (47.4) 15    (78.9) 3     (60.0) 0     (0.0) 12   (92.3) 2    (25.0)
Resistant 2      (18.2) 17     (94.4) 10     (52.6) 4      (21.1) 2     (40.0) 1   4(100) 1      (9.7) 6    (75.0)
Total tested 11    (100) 18     (100) 19     (100) 19    (100) 5    (100) 14  (100) 13   (100) 8     (100)
Pseudomonas spp Sensitive 1      (100) 3     (50.0) 4      (50.0) 0      (0.0) 3    (75.5) - 7     (87.5) 0    (0.0)
Resistant 0       (0.0) 3     (50.0) 4      (50.0) 7     (100) 1     (25.5) - 1     (12.5) 2     (100)
Total tested 1      (100) 6     (100) 8        (100) 7     (100) 4     (100) - 8     (100) 2     (100)
Klebsiella spp Sensitive 4       (100) - 1        (50.0) 0     (0.0) 0     (0.0) 0     (0.0) 4    (100) 0      (0.0)
Resistant 0      (0.0) - 1        (50.0) 2     (100) 2    (100) 4     (100) 0     (0.0) 4    (100)
Total tested 4     (100) - 2     (100) 2    (100) 2    (100) 4  (100) 4     (100) 4   (100)
Discussion:
In this study, majority (62.8%) of the patients with CSOM 
were aged ≤10 year. This is due to children predisposition to 
CSOM because of their relative susceptibility to infection, 
increased mass of lymphoid tissue and Eustachian 
7dysfunction/anatomy . Usually, children have greater tendency 
to develop upper respiratory tract infections which often lead to 
acute otitis media (AOM) and when untreated or poorly treated 
2transform to CSOM aided by the ignorance of the parents . Such 
parents only seek medical attention when the ears start 
discharging. 
11 7Nwabuisi et al  in Ilorin and Okafor  in Enugu had reported 
45% and 33.2% CSOM prevalence among children respectively 
which were lower than was recorded in this study. Could the 
higher prevalence (62.8%) of CSOM in childhood recorded in 
this study be an indication of increasing propensity of this disease 
in our setting? However, male preponderance as obtained in this 
2, 7,9,11study is similar to reports by other workers .
Unilateral disease was more common in the present study. 
Bilateral disease was only recorded in 26.9% of our patients. This 
9, 11, 12agrees with similar study by Oni etal  . However, this is 
7contrasting to the finding of Okafor  in Enugu who reported 
bilateral involvement in 44.3% of  his patients. The higher 
occurrence of unilateral disease in this study  is adjudge good 
because of the expected better prognosis from reduced risk of 
23bilateral hearing loss when the two ears are affected . 
The most common group of isolate recovered in this study 
were coliforms (34.7%). All member of the coliform group could 
not be identified conclusively because of inadequate facility at 
our centre this is a major limitation of this study. .  Other isolates 
included Staphylococcus aureus (26.3%) and Proteus spp (24.2), 
Pseudomonas spp (9.5%) and Klebsiella spp (5.3%). This 
finding slightly differs from those of other studies in our 
environment as Pseudomonas and Proteus were the predominant 
3 7 cause of CSOM as reported by Coker and co  in Lagos, Okafor in 
11Enugu and Nwabuisi et al  in Ilorin.  Other organisms like 
Staphylococcus aureus, Klebsiella and coliforms were also seen 
in these studies. Our inability to characterise the coliforms due to 
sub-optimal laboratory facility, as it is the case with similar 
studies in our setting, was a major setback. This is because 
conclusive identification of all bacterial isolates would have 
added more value to this study with particular reference to 
antibiotic sensitivity test result interpretation. 
Compared with reports from outside Nigeria, Pseudomonas 
spp and Staphylococcus aureus were the major isolates in 
5Singapore  while Proteus, Staphylococcus aureus, Escherichia 
12coli and Klebsiella spp predominated in Ethiopia . Similarly, 
17Ettehad et al  in Ardebil reported that CSOM infections were 
mainly due to Staphylococcus aureus, Pseudomonas spp and 
14Proteus spp. In another study, Oguntibeju  in South Africa 
reported Proteus spp, Klebsiella spp, Escherichia coli, 
Pseudomonas spp, and Staphylococcus aureus as common cause 
of CSOM.  These differences might be due to geographical 
variations, culture and sampling techniques such as 
tympanocentesis or aspiration of middle ear discharge for 
5 microscopy, culture and sensitivity.  However, Loy et al reported  
that 6.6% of CSOM discharge isolates were anaerobes, while  
24 25Brook and  Nikakhlaqh  et al reported 12%  and 13%  of 
anaerobes respectively in their studies. 
All isolates were sensitive to ciprofloxacin and sparfloxacin 
but resistant to erythromycin, cefuroxime and ceftriazone. 
However reasonable sensitivity to ceftazidime was demonstrated 
by Staphylococcus aureus (62.5%), Pseudomonas (75.5%) and 
Proteus spp (60.0%). The pattern of sensitivity displayed by 
bacterial isolates of this study to the quinolones makes them the 
drug of choice for the treatment of CSOM in our centre except 
when contraindicated as in children less than 7 years old in which 
it may be suitable for topical application. It is noteworthy that 
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9, 11, 17, 26similar result had been obtained in past studies  
There are controversies as to the use in CSOM of the 
commonly available local topical antibiotics like the quinolones 
and aminoglycoside. Ciprofloxacin is broad spectrum and active 
against most agents of CSOM with an added advantage of not 
27, 28  being ototoxic . It causes cartilage damage in young animals, 
17which limit its use in children . However there have been 
29-33treatment trials of topical quinolones in otitis media . 
Aminoglycosides like gentamicin have also been shown to be 
5effective against most agents of CSOM . This is against the 
finding in this study as Pseudomonas and Klebsiella were 
completely resistant to this antibiotic. Furthermore, there is 
problem of ototoxicity with its topical usage as evident by few 
reports of hearing loss following its administration to some 
21patients . 
In conclusion, CSOM is most common in children in our 
setting and are caused by bacteria agents mostly sensitive to the 
quinolones.
 Treatment of patients with CSOM in Ido-Ekiti with the 
quinolones is recommended except where contraindicated.
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